Skip to main content
Premium Trial:

Request an Annual Quote

Interpace Diagnostics' ThyraMIR

PDI subsidiary Interpace Diagnostics has launched ThyraMIR, a microRNA gene expression classifier for identifying indeterminate benign and malignant thyroid modules. It is used in combination with the firm's ThyGenX assay to produce a positive or negative cancer test result from thyroid nodule fine needle aspiration procedures.